Group Ebit* (before Bio Chemicals Projects – BCP) came in at DKK 371m. This reflects a margin of 11.3%, a 4.2 percentage point expansion Y/Y, driven by all divisions aside from sweeteners.
Due to the non-cash impairment charge of DKK 700m related to sweeteners, profit for the group came in at a negative DKK 354m.
“We continued to see a positive earnings momentum during the quarter and are encouraged by the results that we’ve achieved this financial year, including our ability to lift our earnings outlook once more,” said CEO Tom Knutzen. “We now expect to achieve our 12.5% Ebit margin (before BCP) milestone already in FY 2010/11 – ie one year ahead of plan.”
Source: Danisco
© FoodBev Media Ltd 2024